Focus topics


Cancer drug: Sanofi acquires stake in biotech company

The French pharmaceutical company Sanofi has made a €300 million investment in the Chinese biotech company Innovent Biologics. The two companies plan to jointly develop two cancer drugs in China, as reported by the business portal Caixin. According to company sources, Innovent has signed a licensing agreement with Sanofi for the exclusive marketing of the drugs.

Continue reading now

Get 30 days of free access to the Decision Brief to read these and more quality news every day.

Are you already a guest at the China.Table? Log in now

Related

    USA invests in Pacific island states
    Travel slump expected for Golden Week
    Taiwan wants to drop hotel quarantine
    China’s reputation is declining rapidly